Ann: Appendix 4C & Company Update - June 18, page-60

MM,
If PAA came out tomorrow and said the tablet works against tumours as expecteed and overcomes the nausea and vomiting or "palatability" issues that have been holding us back, even if only for dogs, and here's the proof - it would change absolutely everything.

The real cause of the troubles is disbelief, and of course this makes PAA easy pickings for rumour mongers who thrive on innuendo and confusion.  And there's heaps of confusion out there about what they mean by "palatability" and the incorrect belief that PAA is touting a "miracle cure" for cancer. But until the company can come out with the above announcement, the company must simply explain itself more clearly on places like it's website in an adult way and perhaps public meetings - preferably Sydney in co-operation with the UNSW - since everything in Perth suffers from a well earned cowboy image - and we've got to hope there are people out there who think that at these gutter level valuations PAA is now worth a punt given the IP it has built  But an expensive mass marketing effort at this point will be a waste of money because the market will say, yeah, sure mate, we've heard it before, and who can blame them for being suspicious ?  They say they've got the tablet, well, the market wants the clinical proof, and the sooner the better, or it may have a very hard time raising any more finance.